Neurocrine Biosciences Inc (NASDAQ:NBIX) - Share price


Stock Report

Neurocrine Biosciences Inc NBIX

Last Price
$80.83

Day Change
-3.67|-4.34%

As of 25/06/2019
16:11:25 EDT | USD
Minimum 15 Minutes Delay.

Last Close84.50
Day Range80.32 - 84.34
Mkt Cap7.38Bil
52-Wk Range64.72 - 126.98
Yield %-
ISINUS64125C1099
Volume960,963
P/E-187.98
P/S14.93
P/CF282.92

Share Price

Financials
201620172018
More ...
Income Statement
Revenue15.00161.63451.24
Operating Income-147.37-131.3636.90
Net Income-141.09-142.5421.11
Basic EPS-1.63-1.620.23
Avg. Diluted Shares Outstanding878895
Balance Sheet
Current Assets310.44554.92737.78
Non Current Assets54.64262.67255.37
Total Assets365.09817.59993.15
Current Liabilities30.4154.4388.23
Total Liabilities50.21445.45512.39
Total Equity314.88372.14480.77
Cash Flow
Operating Cash Flow-106.18-94.33101.36
Capital Expenditure-4.11-6.94-24.81
Free Cash Flow-110.29-101.2776.55

In millions, except "Basic EPS". Currency is USD.

Company Profile

Neurocrine Biosciences Inc engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Mid-Growth

Fiscal Year Ends

December

Employees

585
Key Stats
More ...
Price/Earning TTM-201.19
Price/Book18.85
Price/Sales TTM17.86
Rev Growth (3 year avg)183.67
EPS Growth (3 year avg)-
Operating Margin % TTM8.18
Net Margin % TTM4.68
ROE TTM4.95
Debt/Equity0.81
Dividends
PreviousLatest
More ...
Declared Datet.b.c.09/12/95
Ex-Divt.b.c.29/12/95
Paidt.b.c.t.b.c.
Amnt0.000.04
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.